NasdaqCM - Delayed Quote USD

NKGen Biotech, Inc. (NKGNW)

0.0900
-0.0050
(-5.26%)
At close: June 11 at 3:38:15 PM EDT
全部 全部 Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for NKGNW

Recent News: NKGNW

更多內容
NKGen Biotech Chairman & CEO Paul Y. Song, M.D., Personally Invests $2.65 Million Cash to Accelerate Phase 2 Clinical Trial and Fulfill Financial Reporting Obligations

NKGen Biotech Chairman & CEO Paul Y. Song, M.D., Personally Invests $2.65 Million Cash to Accelerate Phase 2 Clinical Trial and Fulfill Financial Reporting Obligations
GlobeNewswire last month
NKGen Biotech to Present Troculeucel Clinical and Biomarker Results at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting

NKGen Biotech to Present Troculeucel Clinical and Biomarker Results at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
GlobeNewswire last month
NKGen Biotech To Present on the Use of Troculeucel for Alzheimer’s and Parkinson’s Disease at the 7th China International Biotechnology Conference & Exhibition

NKGen Biotech To Present on the Use of Troculeucel for Alzheimer’s and Parkinson’s Disease at the 7th China International Biotechnology Conference & Exhibition
GlobeNewswire last month
NKGen Biotech Presents Data from Phase 1/2a Clinical Trial of Troculeucel in Moderate Alzheimer’s Disease at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2025)

NKGen Biotech Presents Data from Phase 1/2a Clinical Trial of Troculeucel in Moderate Alzheimer’s Disease at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2025)
GlobeNewswire 2 months ago
NKGen Biotech To Present Updated Troculeucel Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2025)

NKGen Biotech To Present Updated Troculeucel Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2025)
GlobeNewswire 2 months ago
Biotech Alert: Searches spiking for these stocks today

Biotech Alert: Searches spiking for these stocks today
TipRanks 2 months ago
NKGen Biotech To Present on Potential of Troculeucel for the Treatment of Neurodegenerative Diseases at the 13th Annual Alzheimer’s & Parkinson’s Drug Development Summit

NKGen Biotech To Present on Potential of Troculeucel for the Treatment of Neurodegenerative Diseases at the 13th Annual Alzheimer’s & Parkinson’s Drug Development Summit
GlobeNewswire 3 months ago
NKGen Biotech, Inc. to Transition from the Nasdaq Global Market to OTC Markets; Reverse Stock Split will not be Implemented

NKGen Biotech, Inc. to Transition from the Nasdaq Global Market to OTC Markets; Reverse Stock Split will not be Implemented
GlobeNewswire 3 months ago
NKGen Biotech Announces Administration of First Dose of Troculeucel to Stroke Patient Under FDA-Cleared Compassionate Use Program

NKGen Biotech Announces Administration of First Dose of Troculeucel to Stroke Patient Under FDA-Cleared Compassionate Use Program
GlobeNewswire 3 months ago
NKGen Biotech Announces Administration of First Dose of Troculeucel to Frontotemporal Dementia Patient Under FDA-Cleared Compassionate Use Program

NKGen Biotech Announces Administration of First Dose of Troculeucel to Frontotemporal Dementia Patient Under FDA-Cleared Compassionate Use Program
GlobeNewswire 3 months ago
NKGen Appoints Dr. Anita Fletcher as National Principal Investigator for Phase 2a Troculeucel Trial Evaluating Moderate Alzheimer’s Disease with AdventHealth Orlando as First East Coast Site

NKGen Appoints Dr. Anita Fletcher as National Principal Investigator for Phase 2a Troculeucel Trial Evaluating Moderate Alzheimer’s Disease with AdventHealth Orlando as First East Coast Site
GlobeNewswire 3 months ago
更多內容

Related Tickers

2LB.MU Iovance Biotherapeutics Inc
1.9688
0.00%
 
N04.MU Nucana PLC R
0.1040
-20.00%
 
N04.SG Nucana PLC (ADRs)
0.0970
-22.40%
 
2LB.BE Iovance Biotherapeutics Inc
1.9324
+1.19%
 
2LB.DU Iovance Biotherapeutics Inc
1.9544
+1.54%
 
2LB.SG Iovance Biotherapeutics Inc
1.9208
-1.05%
 
N04.BE Nucana PLC R
0.1030
-23.13%
 
N04.F NuCana plc
0.1020
-33.77%
 
2LB.F Iovance Biotherapeutics, Inc.
1.9322
+1.19%
 
PHRM.CN PharmaTher Holdings Ltd.
0.2300
+12.20%